Bioresorbable vascular scaffold implantation for the treatment of coronary in-stent restenosis: Results from a multicenter Italian experience

被引：32

作者：

Moscarella, Elisabetta ^{[1
,2
]}

Varricchio, Attilio ^{[1
]}

Stabile, Eugenio ^{[3
]}

Latib, Azeem ^{[4
,5
]}

Ielasi, Alfonso ^{[6
]}

Tespili, Maurizio ^{[6
]}

Cortese, Bernardo ^{[7
]}

Calabro, Paolo ^{[2
]}

Granata, Francesco ^{[1
,2
]}

Panoulas, Vasileios F. ^{[5
]}

Franzone, Anna ^{[3
]}

Trimarco, Bruno ^{[3
]}

Bonzani, Giulio ^{[1
]}

Esposito, Giovanni ^{[3
]}

Colombo, Antonio ^{[4
,5
]}

机构：

[1] Azienda Osped Dei Colli, Presidio Osped Monaldi, Dept Cardiol, Lab Invas Cardiol, Naples, Italy

[2] Univ Naples 2, Azienda Osped Dei Colli, Presidio Osped Monaldi, Lab Invas Cardiol,Dept Cardiol, Naples, Italy

[3] Univ Naples Federico II, Dipartimento Sci Biomed Avanzate, Lab Invas Cardiol, Naples, Italy

[4] EMO GVM Ctr Cuore Columbus, UO Emodinam & Cardiol Interventist, Milan, Italy

[5] Univ Milan, Osped San Raffaele, I-20127 Milan, Italy

[6] UOC Cardiol, Azienda Osped Bolognini Seriate, Bergamo, Italy

[7] Azienda Osped Fatebenefratelli, Lab Invas Cardiol, Milan, Italy

来源：

INTERNATIONAL JOURNAL OF CARDIOLOGY | 2015年 / 199卷

关键词：

BVS; Restenosis; DES; Stent; DRUG-ELUTING STENTS; BALLOON ANGIOPLASTY; RANDOMIZED-TRIAL;

D O I：

10.1016/j.ijcard.2015.07.002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This multicenter experience sought to investigate the feasibility and safety of BVS for the treatment of ISR. From April 2012 to June 2014, a total of 315 patients (334 lesions) underwent PCI for ISR at the participating centers. Of those, 83 patients (90 lesions) received BVS. Procedural success was achieved in all patients. At a median of 7 (IQR 3-18) months follow-up, MACCE rate was 12%, TLR 7.7%, while one (1.1%) definite BVS-in-stent thrombosis was reported. The results of this multicenter experience suggest that BVS implantation for the treatment of coronary ISR is technically feasible and associated with favorable mid-term clinical results. These data could be considered hypothesis generating for a future randomized clinical trial. (C) 2015 Elsevier Ireland Ltd. All rights reserved.

引用

页码：366 / 372

页数：7

共 50 条

[41] Late acquired coronary aneurysm and restenosis after bioresorbable vascular scaffold implantation: a case report
Micari, Antonino
Dimartino, Angelo
Donato, Rocco
Vizzari, Giampiero
Ando, Giuseppe
[J]. EUROPEAN HEART JOURNAL-CASE REPORTS, 2024, 8 (02)
[42] Incidence of definite stent thrombosis or in-stent restenosis after drug-eluting stent implantation for treatment of coronary in-stent restenosis: From Western Denmark heart registry
Jensen, Jesper Khedri
Jensen, Lisette Okkels
Terkelsen, Christian Juhl
Lassen, Jens Flensted
Tilsted, Hans Henrik
Hansen, Knud Noerregaard
Maeng, Michael
Thuesen, Leif
Thayssen, Per
[J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2013, 81 (02) : 260 - 265
[43] Bioresorbable Vascular Scaffolds for Patients With In-Stent Restenosis The RIBS VI Study
Alfonso, Fernando
Cuesta, Javier
Jose Perez-Vizcayno, Maria
Garcia del Blanco, Bruno
Ramon Rumoroso, Jose
Bosa, Francisco
Perez de Prado, Armando
Masotti, Monica
Moreno, Raul
Cequier, Angel
Gutierrez, Hipolito
Garcia Touchard, Arturo
Ramon Lopez-Minguez, Jose
Zueco, Javier
Marti, Vicens
Velazquez, Maite
Moris, Cesar
Bastante, Teresa
Garcia-Guimaraes, Marcos
Rivero, Fernando
Fernandez, Cristina
[J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (18) : 1841 - 1851
[44] Feasibility of overlapped MAGMARIS bioresorbable scaffold implantation in long lesions: results from a multicenter Italian registry
Quadri, G.
Cerrato, E.
Garro, N.
Leoncini, M.
Tomassini, F.
Mariani, F.
Bellucca, S.
Buccheri, D.
Bernelli, C.
Sganzerla, P.
Ferrari, F.
Rolfo, C.
Geraci, S.
Ielasi, A.
Varbella, F.
[J]. EUROPEAN HEART JOURNAL, 2018, 39 : 134 - 134
[45] Safety and Efficacy of Sirolimus Coated Balloon for the Treatment Coronary In-stent Restenosis: Results from Real World Multicenter Study
Dani, Sameer
Parikh, Keyur
Shetty, Ranjan
Kumar, N. Prathap
Hiremath, Jagdish
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (16) : S19 - S19
[46] Sirolimus and paclitaxel eluting stent implantation for diffuse coronary in-stent restenosis
Airoldi, F
Briguori, C
Iakovou, I
Stankovic, G
Carlino, M
Biondi-Zoccai, G
Chieffo, A
Montorfano, M
Cosgrave, J
Sangiorgi, GM
Colombo, A
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (7A): : 167H - 167H
[47] Sirolimus and paclitaxel eluting stent implantation for diffuse coronary in-stent restenosis
Airoldi, F
Briguori, C
Iakovou, I
Stankovic, G
Biondi-Zoccai, G
Carlino, M
Chieffo, A
Montorfano, M
Cosgrave, J
Michev, I
Melzi, G
Colombo, A
[J]. CIRCULATION, 2005, 112 (17) : U714 - U714
[48] Clinical outcomes for Sirolimus-Eluting stent implantation and vascular brachytherapy for the treatment of in-stent restenosis
Saia, F
Lemos, PA
Hoye, A
Sianos, G
Arampatzis, CA
de Feyter, PJ
van der Giessen, WJ
Smits, PC
van Domburg, RT
Serruys, PW
[J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2004, 62 (03) : 283 - 288
[49] Rapamycine eluting stents for the treatment of in-stent restenosis: results from a single centre experience
Rogacka, R
Airoldi, F
Stankovic, G
Tavano, D
Montorfano, M
Chieffo, A
Carlino, M
Colombo, A
[J]. EUROPEAN HEART JOURNAL, 2003, 24 : 430 - 430
[50] Bioresorbable Scaffold As Option For The Treatment Of Coronary In-Stent Restenosis: Result From Single-Centre Prospective Observational Study With Angiographic Follow-Up
Wojcik, Jaroslaw
Madejczyk, Andrzej
Wiorkowski, Krzysztof
Jankiewicz, Marek
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (15) : B206 - B206

← 1 2 3 4 5 →